Genetic variant linked with kidney failure in diabetic women but not men

September 12, 2013

A genetic variant on chromosome 2 is strongly linked with kidney failure in diabetic women but not in men, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may help explain gender-specific differences in kidney failure, as well as why some diabetic women are prone to develop kidney failure.

Worldwide, more than 370 million people have diabetes, which is the leading cause of kidney failure, or end stage . Within the non-diabetic population, women are relatively protected from kidney failure until menopause, but this protection is reduced in diabetic women.

Niina Sandholm, MSc, Per-Henrik Groop, MD, DMSc (Helsinki University Central Hospital and Folkhälsan Research Center, in Finland) and their colleagues designed a study to detect genetic variants that might predispose diabetic women to kidney failure. Their initial study included 3652 Finnish patients with .

The researchers identified a genetic variant on chromosome 2 that was linked with kidney failure in women with type 1 diabetes but not in men. Additional analyses revealed that it was also linked with kidney failure in diabetic women in the United Kingdom, the United States, and Italy. Diabetic women with the risk variant had a nearly two-fold increased risk of developing kidney failure compared with diabetic women who did not have the risk variant.

"This study reports the first genetic variant robustly associated with end stage renal disease in diabetic women but not in men. This finding may give valuable information on how some diabetic women lose their protection against end stage renal disease," said Sandholm. The genetic variant is located close to a gene for a factor that interacts with the and also helps regulate . It will be interesting to see if this factor plays a role in the gender-specific protection against kidney failure seen in this study.

In an accompanying editorial, Marcus Pezzolesi, PhD and Andrzej Krolewski, MD, PhD (Joslin Diabetes Center) noted that "In identifying evidence of an association with end stage renal disease exclusively in women, this study offers the strongest evidence to date of a sex-specific genetic factor for diabetic nephropathy." They added, however, that the findings need to be verified by additional studies.

Explore further: Research aims to prevent diabetic kidney failure

More information: The article, entitled "Chromosome 2q31.1 Associates with ESRD in Women with Type 1 Diabetes," will appear online on September 12, 2013, DOI: 10.1681/ASN.2012111122
The editorial, entitled "Diabetic Nephropathy: Is ESRD Its Only Heritable Phenotype?" will appear online on September 12, 2013, DOI: 10.1681/ASN.2013070769

Related Stories

Research aims to prevent diabetic kidney failure

November 5, 2011
The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.

New target for treating diabetic kidney disease, the leading cause of kidney failure

October 18, 2012
Researchers have discovered a new therapeutic target for diabetic nephropathy, the leading cause of kidney failure. The findings, appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN), ...

Genetic variant identified that may increase heart disease risk among people with type 2 diabetes

August 27, 2013
A newly discovered genetic variant may increase the risk of heart disease in people with type 2 diabetes by more than a third, according to a study led by researchers at Harvard School of Public Health (HSPH) and Joslin Diabetes ...

What's your lifetime risk of developing kidney failure?

August 16, 2012
How likely are middle-aged adults to develop kidney failure during their lifetime? A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides some insights, which may be used ...

Vitamin B derivative helps diabetics with mild kidney disease

October 27, 2011
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). ...

Researchers replicate human kidney gene changes in mouse model

May 23, 2011
University of Louisville researchers have replicated the inflammatory gene changes of a human kidney as it progresses from mild to severe diabetic nephropathy, using a mouse model developed by a UofL researcher, according ...

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.